Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Senti Biosciences (SNTI) Return on Equity (2021 - 2025)

Senti Biosciences has reported Return on Equity over the past 5 years, most recently at 0.1% for Q4 2025.

  • For Q4 2025, Return on Equity changed N/A year-over-year to 0.1%; the TTM value through Dec 2025 reached 0.1%, changed N/A, while the annual FY2025 figure was 0.04%, N/A changed from the prior year.
  • Return on Equity for Q4 2025 was 0.1% at Senti Biosciences, down from 0.03% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q2 2024 and troughed at 0.1% in Q4 2025.
  • A 5-year average of 0.01% and a median of 0.0% in 2022 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: increased 3bps in 2023 and later fell -3bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2021, then crashed by -245bps to 0.0% in 2022, then skyrocketed by 150bps to 0.0% in 2023, then plummeted by -101bps to 0.0% in 2024, then crashed by -1062929bps to 0.1% in 2025.
  • Business Quant data shows Return on Equity for SNTI at 0.1% in Q4 2025, 0.03% in Q3 2025, and 0.01% in Q2 2025.